Literature DB >> 32484455

The changing investment in translational science by academic medical centers: HOPE in the Valley of Death.

Lucy Y Ghoda1,2, Steven T Rosen1,3,4, Larry W Kwak1,3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32484455      PMCID： PMC7324205          DOI： 10.1172/JCI138640

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  5 in total

1.  CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.

Authors:  Hong Qin; Zhenyuan Dong; Xiuli Wang; Wesley A Cheng; Feng Wen; Weili Xue; Han Sun; Miriam Walter; Guowei Wei; D Lynne Smith; Xiuhua Sun; Fan Fei; Jianming Xie; Theano I Panagopoulou; Chun-Wei Chen; Joo Y Song; Ibrahim Aldoss; Clarisse Kayembe; Luisa Sarno; Markus Müschen; Giorgio G Inghirami; Stephen J Forman; Larry W Kwak
Journal:  Sci Transl Med       Date:  2019-09-25       Impact factor: 17.956

2.  The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro.

Authors:  Mei-Chuan Chen; Bingsen Zhou; Keqiang Zhang; Yate-Ching Yuan; Frank Un; Shuya Hu; Chih-Ming Chou; Chun-Han Chen; Jun Wu; Yan Wang; Xiyong Liu; D Lynne Smith; Hongzhi Li; Zheng Liu; Charles D Warden; Leila Su; Linda H Malkas; Young Min Chung; Mickey C-T Hu; Yun Yen
Journal:  Mol Pharmacol       Date:  2015-03-26       Impact factor: 4.436

3.  Surveying the best in translation.

Authors:  Matthew Grunseth; Calvin Chen; Ryan Kelly; Sangeeta Bardhan Cook; George Megaw; Larry Couture
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

4.  A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.

Authors:  Bingsen Zhou; Leila Su; Shuya Hu; Weidong Hu; M L Richard Yip; Jun Wu; Shikha Gaur; D Lynne Smith; Yate-Ching Yuan; Timothy W Synold; David Horne; Yun Yen
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

5.  Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo.

Authors:  Hong Qin; Guowei Wei; Ippei Sakamaki; Zhenyuan Dong; Wesley A Cheng; D Lynne Smith; Feng Wen; Han Sun; Kunhwa Kim; Soungchul Cha; Laura Bover; Sattva S Neelapu; Larry W Kwak
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.